Timothy Scannell

Mr. Timothy J.
Scannell is an Independent Director at NovoCure Ltd., an Independent Chairman at Insulet Corp.
and a Chairman at Synaptive Medical, Inc. He is on the Board of Directors at Cerebral Therapeutics, Inc., Regenity Biosciences, NovoCure Ltd. and CereVasc, Inc. Mr. Scannell was previously employed as an Independent Director by Masimo Corp., an Independent Director by EXACT Sciences Corp., an Independent Director by AeroClean Technologies, Inc., an Independent Director by Molekule Group, Inc., an Independent Non-Executive Director by Renalytix Plc, a President by Stryker Spine, a Vice President & General Manager by Stryker Biotech LLC, and a President & Chief Operating Officer by Stryker Corp.
He also served on the board at Entellus Medical, Inc. He received his undergraduate degree from the University of Notre Dame and an MBA from the University of Notre Dame.